This inventor holds 2 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 2025.
Company Filing History:
2 out of 3,071 
2 out of 1,424 
Years Active: 2025
Title: The Innovative Contributions of Eric Garland Sheu
Introduction
Eric Garland Sheu is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of metabolic disorders and inflammatory diseases. With a total of 2 patents, Sheu's work focuses on innovative solutions that address critical health issues.
Latest Patents
Sheu's latest patents include groundbreaking research on synthetic derivatives of cholic acid 7-sulfate. One of his key inventions relates to the discovery of cholic acid 7-sulfate as a treatment for diabetes. This patent outlines methods for treating various metabolic disorders, including diabetes and obesity, by administering compounds derived from cholic acid 7-sulfate. Additionally, he has developed compositions and kits that utilize cholic acid 7-sulfate for therapeutic purposes, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Sheu has worked with prestigious institutions such as Harvard College and Brigham and Women's Hospital, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his research and innovation capabilities.
Collaborations
Some of Sheu's notable coworkers include Abigail Sloan Devlin and David A Harris. Their collaborative efforts have contributed to the advancement of research in the medical field, particularly in the areas of metabolic and inflammatory diseases.
Conclusion
Eric Garland Sheu's innovative work in the field of medicine, particularly through his patents on cholic acid 7-sulfate, demonstrates his dedication to improving health outcomes. His contributions are paving the way for new treatments that could significantly impact the lives of individuals suffering from metabolic disorders and inflammatory diseases.